NCT05171049 2026-02-23
ASTER
Anthos Therapeutics, Inc.
Phase 3 Terminated
Anthos Therapeutics, Inc.
Anthos Therapeutics, Inc.
Academic and Community Cancer Research United
The University of Hong Kong
Daiichi Sankyo
Rovi Pharmaceuticals Laboratories
Ontario Clinical Oncology Group (OCOG)